VIRTUAL CONFERENCE

From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You’ll hear from experts at Deloitte, Ernst & Young, Effectus Group, life science analysts and your industry counterparts.

LEARNING OBJECTIVES:

  • Understand the latest accounting changes in key areas
  • Recognize the timelines and key factors affecting the life science industry
  • Begin to assess the effects of these standards on your company or clients

REGISTRATION INFORMATION:

Cost: $545 (save $150 off the regular price of $695 if you register by August 4th).
This event will run 8:45-4:40p (PST) each day.

REGISTER NOW »

Register any one of three ways:
1. Register online using a credit card and click the orange button
2. Register by phone at (610) 789-3110 
3. Email your contact info to be invoiced to mtarman@acslive.com


Agenda: DAY 1
8:4510:10Accounting for R&D and Clinical Trials
R&D Funding Arrangements
R&D Cost Classifications
SEC Comment Letter Trends
10:1010:25Break
10:2511:45ESG
SEC & ISSB Updates
Lessons learned from SOX
ESG Governance and process
Practical examples
11:4512:25Lunch Break
12:251:40Gross to Net
Introduction and Overview
Industry View
Estimation Methodology
Approaching Launch
Key Challenges
SEC Comments
Close and Financial Reporting
GTN Hot Topics Discussion
1:401:50Break
1:503:05Tax Update
Latest legislative developments
Key Tax Proposals
Build Back Better Act Observations
Possible timing and other legislative priorities
3:053:10Break
3:104:40SEC & PCAOB Update
Leadership
Current Landscape
Rulemaking Update
CAQ regulations committee meeting highlights
Emerging issues
SEC Comments
Resources
Agenda: DAY 2
8:4510:00Financial Accounting Update
Current projects
Presentation and disclosure projects
Selected ASUs issued in 2022
10:0010:10Break
10:1011:25Revenue Recognition Update
Cases and examples
Interaction of 808 and 606
Evaluating “active participation”
Measure of progress
SEC comment letter themes
ASC 606 Implementation issues and lessons learned in the life science industry
11:2511:35Break
11:3512:55Automation in Life Sciences
AI - where companies are finding best use
Practical examples
12:551:30Lunch Break
1:303:00Fraud and Cybersecurity in Life Sciences
Recent Trends
Cases and Examples
New threats from COVID
Ransomware
3:003:15Break
3:154:30SOX & Internal Controls Update
Management Review Controls
Information Used in Controls (IUC)
IT considerations
SOX Optimization and Modernization
Conference Series Speakers Include:
Nathan Mitchell Deloitte, Partner
Tori Hack Ernst & Young, Senior Manager, ESG & Sustainability Services
Jenna Shintaku Ernst & Young, Audit Manager
Nick Lubold Deloitte, Manager
Storme Sixeas Deloitte, Senior Tax Manager
Christie Hutchinson Effectus Group, Director
Adam Barrow Effectus Group, Director
Dan Lujan Ernst & Young, Partner
Ryan Dolan CFGI, Life Sciences Leader and Regional Co-Managing Partner
Dan Sawicki CFGI, Senior Manager
Melanie Walker CFGI, Managing Director
Skyler Kersten Deloitte, Manager National Office Accounting Services
Taher Jamshidi Ernst & Young, Senior Manager
Kariuki Ndegwa Ernst & Young, Senior Manager
Michelle Chan Deloitte, Manager National Office Accounting Services
Katy Rossino Deloitte, Senior Manager National Office Accounting Services
Isaac Lawrence Thomas Deloitte, Manager National Office Accounting Services
Sarah Serufusa Ernst & Young, Senior Manager
Ron Johnson Ernst & Young, Senior Manager
Steve Abrahamson Ernst & Young, Executive Director
Sean Kennedy Deloitte, Audit Senior Manager
Abby Cohen Deloitte, Audit Senior Manager